Schizophrenia Drug Linked to Pneumonia, Gut Disorders in 25-Year Follow-Up Study
By Huey Freeman Recent research has linked clozapine, a powerful medication for schizophrenia, to an increased risk of mortality associated with pneumonia and severe gastrointestinal complications. Clozapine is the only drug in the United States approved to treat “treatment-resistant schizophrenia,” which affects one in five schizophrenic patients. It was removed from global markets in…
More Stories
General Dynamics Co. (NYSE:GD) Sees Significant Increase in Short Interest
General Dynamics Co. (NYSE:GD – Get Free Report) was the target of a large increase in short interest in the...
Byline Bancorp, Inc. (NYSE:BY) Short Interest Update
Byline Bancorp, Inc. (NYSE:BY – Get Free Report) was the recipient of a large growth in short interest in the...
Effective GSA Contract Management: How to Avoid Financial and Administrative Errors
Managing General Services Administration (GSA) contracts is a critical endeavor for businesses aiming to access the lucrative federal marketplace. Effective...
Onex Co. (OTCMKTS:ONEXF) to Issue Dividend of $0.07
Onex Co. (OTCMKTS:ONEXF – Get Free Report) announced a dividend on Wednesday, January 1st,investing.com reports. Stockholders of record on Monday,...
Nexus Industrial REIT (NXR.UN) To Go Ex-Dividend on December 31st
Nexus Industrial REIT (TSE:NXR.UN – Get Free Report) declared a monthly dividend on Tuesday, December 31st,TickerTech Dividends reports. Investors of...
Amentum (NYSE:AMTM) Shares Down 2.9% – Time to Sell?
Amentum Holdings, Inc. (NYSE:AMTM – Get Free Report)’s stock price traded down 2.9% during trading on Tuesday . The company...